InvestorsHub Logo

DonDonDonDon

04/15/21 12:31 PM

#159070 RE: Dieselpro #159065

CytoDyn has over ONE MILLION vials to sell! It's a good thing lenz has zero inventory because nobody wants it!!!


HGEN currently has enough lenzilumab for 100,000 treatments. At $10,000 per treatment, that is $1 billion in revenue. The government, through Operation Warp Speed, has reserved production facilities to produce lenz. HGEN has $200 million in their war chest to seriously ramp up production. HGEN believes it will have $1 billion in revenue in 2021 alone. $10-$20 billion in revenue in 2022 is realistic. HGEN currently has a market cap of $800 million.

Nader attacked HGEN in the last CC because he fears lenzilumab.